Tag: In the News,better NSCLC outcomes,lung cancer testing,proteomic testing
-
Study: Better NSCLC Outcomes with Proteomic Test
The VeriStrat proteomic test, when used to help guide treatment of patients with advanced non-small cell lung cancer, improves overall survival and decreases medical costs in the U.S. payer system, said a study published recently in the journal Lung Cancer.